investing-statsSEC Form 4 insider transactions

VCEL · Vericel Corp

← all insiders

Biological Products, (No Diagnostic Substances) · Listed on Nasdaq

Open-market insider flow over 30d · 90d · 180d · 365d · filter in table · CSV · JSON

Open-market trades13
Distinct insiders6
Bought$0
Sold$3.49M
Net flow$-3.49M

Recent filings

How to read this

Filed
Date the Form 4 was filed with the SEC. Insiders must file within 2 business days of the trade.
Ticker
The issuer's stock symbol. Select it to open that company's insider-activity page.
Issuer
The company whose shares were traded.
Sector
The issuer's industry (SEC SIC classification). Select a value to filter to that sector.
Insider
The reporting person: an officer, director, or 10% owner. Select a name to see all of their trades.
Role
The insider's relationship to the company: director, officer, or 10% owner.
Code
SEC transaction code describing the kind of transaction. Full official definitions are under “Transaction codes” below. A dot marks an open-market trade (P/S), the highest-conviction signal.
Side
Direction of the trade, from the filing's Acquired (A) ▲ / Disposed of (D) ▼ field: a buy or a sell.
10b5-1
Trade made under a pre-arranged Rule 10b5-1 plan: scheduled in advance, not a discretionary decision (generally lower signal).
Shares
Number of shares in this transaction.
Price
Reported price per share. Blank for grants, gifts, and other trades with no stated price.
Value
Transaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ for their impact).
Owned after
Form 4 column “Amount of Securities Beneficially Owned Following Reported Transaction(s)”: shares the insider held (directly or indirectly) immediately after this trade.
Own Δ
How much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.
Co. Δ
Change in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake. Based on the latest reported shares outstanding; blank when unavailable.
D/I
Form 4 column “Ownership Form: Direct (D) or Indirect (I)”. Indirect holdings (for example, through a trust, fund, or family member) are detailed in the filing's “Nature of Indirect Beneficial Ownership.”
Lag
Days from the trade date to the filing date (Form 4 is due within 2 business days).

Transaction codes

Verbatim from the SEC's General Instructions for Forms 3, 4 and 5.

P
Open market or private purchase of non-derivative or derivative security
S
Open market or private sale of non-derivative or derivative security
A
Grant, award or other acquisition pursuant to Rule 16b-3(d)
D
Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
F
Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
M
Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
G
Bona fide gift
C
Conversion of derivative security
X
Exercise of in-the-money or at-the-money derivative security
J
Other acquisition or disposition (describe transaction)
Recent Form 4 filings for VCEL
FiledDate the Form 4 was filed with the SEC (due within 2 business days of the trade).InsiderRoleCodeSEC transaction code describing the kind of transaction. See “How to read this” above for the official SEC definition of each code. The dot marks an open-market trade (P/S).SideDirection of the trade: a buy (acquired ▲) or a sell (disposed ▼).SharesNumber of shares in this transaction.PriceReported price per share. Blank for trades with no stated price.ValueTransaction value = shares × price. Left blank for grants, option exercises, gifts, and conversions, which have no cash price (see Own Δ).Owned afterShares the insider held (directly or indirectly) immediately after this trade.Own ΔHow much this trade changed the insider's own holding versus what they held just before it (not a share of the company). +45% grew it by 45%, 2.0× more than doubled it, −100% sold the entire stake, “new” built a position from nothing.Co. ΔChange in the insider's stake as a share of the whole company from this trade (transaction shares ÷ shares outstanding). The “(now …)” figure is their resulting total stake in the company. Based on the latest reported shares outstanding; blank when unavailable.Link to SEC filing
2026-08-14MCLAUGHLIN KEVIN FDirectorM buy10b5-17,000 7,000 Common Stock7,000filing
2026-08-14MCLAUGHLIN KEVIN FDirectorS sell10b5-17,0000$44.53$311.7K18,300−28%−0.01% (now 0.04%)filing
2026-08-14MCLAUGHLIN KEVIN FDirectorM buy10b5-17,0000$13.05$91.3K25,300+38%+0.01% (now 0.05%)filing
2026-08-05Halpin MichaelOfficer (Chief Operating Officer)M buy10b5-110,000 10,000 Common Stock26,250filing
2026-08-05Halpin MichaelOfficer (Chief Operating Officer)S sell10b5-110,0000$46.84$468.4K16,394−38%−0.02% (now 0.03%)filing
2026-08-05Halpin MichaelOfficer (Chief Operating Officer)M buy10b5-110,0000$16.66$166.6K26,394+61%+0.02% (now 0.05%)filing
2026-07-31SIEGAL JONATHANOfficer (Principal Accounting Officer)M buy10b5-1500 500 Common Stock3,500filing
2026-07-31SIEGAL JONATHANOfficer (Principal Accounting Officer)M buy10b5-12,500 2,500 Common Stock4,000filing
2026-07-31SIEGAL JONATHANOfficer (Principal Accounting Officer)M buy10b5-11,500 1,500 Common Stock2,698filing
2026-07-31SIEGAL JONATHANOfficer (Principal Accounting Officer)S sell10b5-15000$48.90$24.4K1,078−32%−<0.01% (now <0.01%)filing
2026-07-31SIEGAL JONATHANOfficer (Principal Accounting Officer)M buy10b5-15000$29.82$14.9K1,578+46%+<0.01% (now <0.01%)filing
2026-07-31SIEGAL JONATHANOfficer (Principal Accounting Officer)S sell10b5-12,5000$48.90$122.3K1,078−70%−<0.01% (now <0.01%)filing
2026-07-31SIEGAL JONATHANOfficer (Principal Accounting Officer)M buy10b5-12,5000$29.82$74.5K3,5783.3×+<0.01% (now <0.01%)filing
2026-07-31SIEGAL JONATHANOfficer (Principal Accounting Officer)S sell10b5-11,5000$48.90$73.3K1,078−58%−<0.01% (now <0.01%)filing
2026-07-31SIEGAL JONATHANOfficer (Principal Accounting Officer)M buy10b5-11,5000$34.90$52.4K2,5782.4×+<0.01% (now <0.01%)filing
2026-06-30SIEGAL JONATHANOfficer (Principal Accounting Officer)M buy10b5-12,500 2,500 Common Stock6,500filing
2026-06-30SIEGAL JONATHANOfficer (Principal Accounting Officer)S sell10b5-12,5000$44.90$112.3K886−74%−<0.01% (now <0.01%)filing
2026-06-30SIEGAL JONATHANOfficer (Principal Accounting Officer)M buy10b5-12,5000$29.82$74.5K3,3863.8×+<0.01% (now <0.01%)filing
2026-06-30SIEGAL JONATHANOfficer (Principal Accounting Officer)S sell10b5-12320$44.90$10.4K886−21%−<0.01% (now <0.01%)filing
2026-06-30Mara Joseph Anthony JrOfficer (Chief Financial Officer)S sell10b5-15,0000$44.75$223.8K16,009−24%−<0.01% (now 0.03%)filing
2026-06-30Hopper Jonathan MarkOfficer (Chief Medical Officer)M buy10b5-15,000 5,000 Common Stock20,000filing
2026-06-30Hopper Jonathan MarkOfficer (Chief Medical Officer)M buy10b5-15,000 5,000 Common Stock25,000filing
2026-06-30Hopper Jonathan MarkOfficer (Chief Medical Officer)S sell10b5-15,0000$45.00$225.0K75,753−6%−<0.01% (now 0.15%)filing
2026-06-30Hopper Jonathan MarkOfficer (Chief Medical Officer)M buy10b5-15,0000$29.82$149.1K80,753+7%+<0.01% (now 0.16%)filing
2026-06-30Hopper Jonathan MarkOfficer (Chief Medical Officer)S sell10b5-15,0000$45.00$225.0K75,753−6%−<0.01% (now 0.15%)filing
2026-06-30Hopper Jonathan MarkOfficer (Chief Medical Officer)M buy10b5-15,0000$29.82$149.1K80,753+7%+<0.01% (now 0.16%)filing
2026-06-30Flynn Sean C.Officer (Chief Legal Officer)M buy10b5-115,000 15,000 Common Stock55,000filing
2026-06-30Flynn Sean C.Officer (Chief Legal Officer)S sell10b5-115,0000$45.64$684.6K1,647−90%−0.03% (now <0.01%)filing
2026-06-30Flynn Sean C.Officer (Chief Legal Officer)M buy10b5-115,0000$16.25$243.8K16,64710×+0.03% (now 0.03%)filing
2026-06-22Halpin MichaelOfficer (Chief Operating Officer)M buy10b5-110,000 10,000 Common Stock36,250filing
2026-06-22Halpin MichaelOfficer (Chief Operating Officer)S sell10b5-110,0000$40.24$402.4K16,248−38%−0.02% (now 0.03%)filing
2026-06-22Halpin MichaelOfficer (Chief Operating Officer)M buy10b5-110,0000$16.66$166.6K26,248+62%+0.02% (now 0.05%)filing
2026-06-22Flynn Sean C.Officer (Chief Legal Officer)M buy10b5-115,000 15,000 Common Stock70,000filing
2026-06-22Flynn Sean C.Officer (Chief Legal Officer)S sell10b5-115,0000$40.21$603.1K1,647−90%−0.03% (now <0.01%)filing
2026-06-22Flynn Sean C.Officer (Chief Legal Officer)M buy10b5-115,0000$16.25$243.8K16,64710×+0.03% (now 0.03%)filing
2026-06-04Hopper Jonathan MarkOfficer (Chief Medical Officer)M buy10b5-14,375 4,375 Common Stock1,625filing
2026-06-04Hopper Jonathan MarkOfficer (Chief Medical Officer)S sell10b5-14,3750$35.00$153.1K75,753−5%−<0.01% (now 0.15%)filing
2026-06-04Hopper Jonathan MarkOfficer (Chief Medical Officer)M buy10b5-14,3750$16.66$72.9K80,128+6%+<0.01% (now 0.16%)filing
2026-05-15MCLAUGHLIN KEVIN FDirectorM buy10b5-13,500 3,500 Common Stock14,000filing
2026-05-15MCLAUGHLIN KEVIN FDirectorM buy10b5-13,500 3,500 Common Stock0filing
2026-05-15MCLAUGHLIN KEVIN FDirectorS sell10b5-13,5000$32.82$114.9K18,300−16%−<0.01% (now 0.04%)filing
2026-05-15MCLAUGHLIN KEVIN FDirectorM buy10b5-13,5000$13.05$45.7K21,800+19%+<0.01% (now 0.04%)filing
2026-05-15MCLAUGHLIN KEVIN FDirectorS sell10b5-13,5000$32.83$114.9K18,300−16%−<0.01% (now 0.04%)filing
2026-05-15MCLAUGHLIN KEVIN FDirectorM buy10b5-13,5000$2.63$9.2K21,800+19%+<0.01% (now 0.04%)filing
2026-05-13Wotton Paul KDirectorS sell7,5000$32.64$244.8K18,802−29%−0.01% (now 0.04%)filing
2026-05-13Wotton Paul KDirectorS sell2,5000$33.05$82.6K26,302−9%−<0.01% (now 0.05%)filing
2026-05-08SIEGAL JONATHANOfficer (Principal Accounting Officer)S sell10b5-11,4220$40.50$57.6K1,118−56%−<0.01% (now <0.01%)filing
2026-05-08SIEGAL JONATHANOfficer (Principal Accounting Officer)S sell10b5-13,4330$38.00$130.5K2,540−57%−<0.01% (now <0.01%)filing
2026-05-08Mara Joseph Anthony JrOfficer (Chief Financial Officer)S sell10b5-15,0000$40.50$202.5K21,009−19%−<0.01% (now 0.04%)filing
2026-05-01Wotton Paul KDirectorA buy3,200 3,200 Common Stock3,200filing
2026-05-01Wotton Paul KDirectorA buy8,000 8,000 Common Stock8,000filing
2026-05-01Wotton Paul KDirectorM buy3,200 3,200 Common Stock0filing
2026-05-01Wotton Paul KDirectorM buy3,200028,802+12%+<0.01% (now 0.06%)filing
2026-05-01ZERBE ROBERT L MDDirectorA buy3,200 3,200 Common Stock3,200filing
2026-05-01ZERBE ROBERT L MDDirectorA buy8,000 8,000 Common Stock8,000filing
2026-05-01ZERBE ROBERT L MDDirectorM buy3,200 3,200 Common Stock0filing
2026-05-01ZERBE ROBERT L MDDirectorM buy3,200032,995+11%+<0.01% (now 0.06%)filing
2026-05-01WRIGHT LISADirectorA buy3,200 3,200 Common Stock3,200filing
2026-05-01WRIGHT LISADirectorA buy8,000 8,000 Common Stock8,000filing
2026-05-01WRIGHT LISADirectorM buy3,200 3,200 Common Stock0filing
2026-05-01WRIGHT LISADirectorM buy3,200015,851+25%+<0.01% (now 0.03%)filing
2026-05-01Rubino Alan LDirectorA buy3,200 3,200 Common Stock3,200filing
2026-05-01Rubino Alan LDirectorA buy8,000 8,000 Common Stock8,000filing
2026-05-01Rubino Alan LDirectorM buy3,200 3,200 Common Stock0filing
2026-05-01Rubino Alan LDirectorM buy3,200064,194+5%+<0.01% (now 0.13%)filing
2026-05-01MCLAUGHLIN KEVIN FDirectorA buy3,200 3,200 Common Stock3,200filing
2026-05-01MCLAUGHLIN KEVIN FDirectorA buy8,000 8,000 Common Stock8,000filing
2026-05-01MCLAUGHLIN KEVIN FDirectorM buy3,200 3,200 Common Stock0filing
2026-05-01MCLAUGHLIN KEVIN FDirectorM buy3,200018,300+21%+<0.01% (now 0.04%)filing
2026-05-01Hagen HeidiDirectorA buy3,200 3,200 Common Stock3,200filing
2026-05-01Hagen HeidiDirectorA buy8,000 8,000 Common Stock8,000filing
2026-05-01Hagen HeidiDirectorM buy3,200 3,200 Common Stock0filing
2026-05-01Hagen HeidiDirectorM buy3,200035,050+10%+<0.01% (now 0.07%)filing
2026-04-06Hopper Jonathan MarkOfficer (Chief Medical Officer)M buy10b5-13,472 3,472 Common Stock9,132filing
2026-04-06Hopper Jonathan MarkOfficer (Chief Medical Officer)S sell10b5-13,4720$35.00$121.5K75,556−4%−<0.01% (now 0.15%)filing
2026-04-06Hopper Jonathan MarkOfficer (Chief Medical Officer)M buy10b5-13,4720$10.95$38.0K79,028+5%+<0.01% (now 0.15%)filing
2026-03-27Rubino Alan LDirectorM buy15,000 15,000 Common Stock0filing
2026-03-27Rubino Alan LDirectorM buy15,0000$2.76$41.4K60,994+33%+0.03% (now 0.12%)filing
2026-03-25Hagen HeidiDirectorM buy10b5-115,000 15,000 Common Stock0filing
2026-03-25Hagen HeidiDirectorS sell10b5-115,0000$32.41$486.1K31,850−32%−0.03% (now 0.06%)filing
2026-03-25Hagen HeidiDirectorM buy10b5-115,0000$2.76$41.4K46,850+47%+0.03% (now 0.09%)filing

Up to 200 most recent filings · select a heading to sort, or open “How to read this” above for definitions · this company on SEC EDGAR.